Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thyroid Neoplasms | 21 | 2023 | 2332 | 4.280 |
Why?
|
Thyroid Nodule | 7 | 2023 | 764 | 2.290 |
Why?
|
Adenoma, Oxyphilic | 3 | 2022 | 148 | 1.960 |
Why?
|
Adenocarcinoma, Follicular | 5 | 2023 | 323 | 1.780 |
Why?
|
Carcinoma, Papillary | 5 | 2023 | 785 | 1.390 |
Why?
|
Cytodiagnosis | 4 | 2022 | 447 | 1.310 |
Why?
|
Salivary Gland Neoplasms | 2 | 2024 | 304 | 1.240 |
Why?
|
Thyroid Gland | 4 | 2022 | 1168 | 1.240 |
Why?
|
Adenoma, Pleomorphic | 2 | 2024 | 75 | 1.040 |
Why?
|
Oxyphil Cells | 2 | 2022 | 56 | 0.860 |
Why?
|
Carcinoma, Acinar Cell | 1 | 2020 | 62 | 0.700 |
Why?
|
Receptors, Steroid | 1 | 2020 | 156 | 0.680 |
Why?
|
Receptors, Thyroid Hormone | 1 | 2020 | 199 | 0.680 |
Why?
|
Biopsy, Fine-Needle | 7 | 2023 | 1118 | 0.640 |
Why?
|
Carcinoma, Neuroendocrine | 2 | 2022 | 339 | 0.550 |
Why?
|
DNA Mismatch Repair | 1 | 2019 | 428 | 0.520 |
Why?
|
In Situ Hybridization | 1 | 2019 | 1900 | 0.500 |
Why?
|
Parathyroid Diseases | 1 | 2014 | 46 | 0.470 |
Why?
|
Microscopy, Polarization | 1 | 2014 | 89 | 0.470 |
Why?
|
Calcium Oxalate | 1 | 2014 | 75 | 0.460 |
Why?
|
Frozen Sections | 1 | 2014 | 153 | 0.450 |
Why?
|
Thyroidectomy | 4 | 2020 | 907 | 0.430 |
Why?
|
Parathyroid Glands | 1 | 2014 | 518 | 0.410 |
Why?
|
Neoplasm Invasiveness | 4 | 2022 | 3595 | 0.390 |
Why?
|
Head and Neck Neoplasms | 3 | 2022 | 2895 | 0.390 |
Why?
|
Papillomavirus Infections | 2 | 2022 | 1613 | 0.370 |
Why?
|
Thyroid Diseases | 1 | 2014 | 386 | 0.370 |
Why?
|
RNA, Viral | 1 | 2019 | 2846 | 0.370 |
Why?
|
Aged, 80 and over | 14 | 2022 | 58976 | 0.300 |
Why?
|
World Health Organization | 2 | 2022 | 1322 | 0.240 |
Why?
|
Aged | 18 | 2022 | 169289 | 0.220 |
Why?
|
Baltimore | 1 | 2024 | 231 | 0.220 |
Why?
|
Immunohistochemistry | 4 | 2020 | 11076 | 0.210 |
Why?
|
DNA-Binding Proteins | 1 | 2020 | 9606 | 0.210 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2023 | 2057 | 0.210 |
Why?
|
Middle Aged | 19 | 2024 | 220895 | 0.210 |
Why?
|
Neoplasm Staging | 3 | 2021 | 11121 | 0.190 |
Why?
|
Mitotic Index | 1 | 2021 | 162 | 0.180 |
Why?
|
Adult | 15 | 2021 | 221177 | 0.170 |
Why?
|
Humans | 30 | 2024 | 761504 | 0.170 |
Why?
|
Carcinoma, Ductal | 1 | 2020 | 97 | 0.170 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2020 | 89 | 0.170 |
Why?
|
Necrosis | 2 | 2022 | 1611 | 0.170 |
Why?
|
Cytological Techniques | 1 | 2021 | 218 | 0.170 |
Why?
|
Breath Tests | 1 | 2020 | 299 | 0.160 |
Why?
|
Alphapapillomavirus | 1 | 2022 | 218 | 0.160 |
Why?
|
Carcinoma | 2 | 2023 | 2330 | 0.160 |
Why?
|
Smoke | 1 | 2020 | 235 | 0.160 |
Why?
|
MutS Homolog 2 Protein | 1 | 2019 | 197 | 0.160 |
Why?
|
Young Adult | 7 | 2020 | 59243 | 0.160 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2021 | 638 | 0.160 |
Why?
|
Male | 18 | 2024 | 360804 | 0.160 |
Why?
|
Mouth Neoplasms | 1 | 2024 | 596 | 0.150 |
Why?
|
Cohort Studies | 6 | 2020 | 41487 | 0.150 |
Why?
|
Gene Fusion | 1 | 2021 | 356 | 0.150 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2020 | 262 | 0.150 |
Why?
|
Female | 18 | 2024 | 392644 | 0.150 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2024 | 4026 | 0.140 |
Why?
|
Carbon Monoxide | 1 | 2020 | 547 | 0.140 |
Why?
|
Papillomaviridae | 2 | 2022 | 1119 | 0.140 |
Why?
|
Precancerous Conditions | 1 | 2024 | 980 | 0.140 |
Why?
|
Prognosis | 5 | 2023 | 29625 | 0.140 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2019 | 698 | 0.130 |
Why?
|
DNA, Viral | 2 | 2022 | 2202 | 0.130 |
Why?
|
Pathology, Molecular | 1 | 2019 | 328 | 0.130 |
Why?
|
Birefringence | 1 | 2014 | 54 | 0.120 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14666 | 0.120 |
Why?
|
Diagnosis, Differential | 3 | 2020 | 12974 | 0.120 |
Why?
|
Disease-Free Survival | 2 | 2021 | 6814 | 0.110 |
Why?
|
Crystallization | 1 | 2014 | 534 | 0.110 |
Why?
|
Retrospective Studies | 8 | 2023 | 80636 | 0.100 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15266 | 0.090 |
Why?
|
Intraoperative Care | 1 | 2014 | 767 | 0.090 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 2827 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6484 | 0.090 |
Why?
|
Neoplasm Metastasis | 1 | 2020 | 4915 | 0.080 |
Why?
|
Lymph Nodes | 1 | 2021 | 3466 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2019 | 5247 | 0.080 |
Why?
|
Adolescent | 4 | 2020 | 88319 | 0.070 |
Why?
|
Adenoma | 1 | 2017 | 2160 | 0.070 |
Why?
|
Adenocarcinoma | 1 | 2023 | 6346 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2022 | 20098 | 0.060 |
Why?
|
Transcription Factors | 1 | 2024 | 12128 | 0.060 |
Why?
|
Smoking | 1 | 2020 | 9053 | 0.060 |
Why?
|
Gene Expression Profiling | 2 | 2017 | 9420 | 0.060 |
Why?
|
Leukoplakia, Oral | 1 | 2024 | 77 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9280 | 0.050 |
Why?
|
Phenotype | 1 | 2020 | 16591 | 0.050 |
Why?
|
Mutation | 3 | 2023 | 30052 | 0.050 |
Why?
|
Risk Assessment | 2 | 2019 | 23995 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11742 | 0.040 |
Why?
|
Ki-67 Antigen | 1 | 2022 | 629 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2021 | 64680 | 0.040 |
Why?
|
Salvage Therapy | 1 | 2021 | 1264 | 0.030 |
Why?
|
Child | 1 | 2020 | 80153 | 0.020 |
Why?
|
Tumor Burden | 1 | 2017 | 1893 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2024 | 3877 | 0.020 |
Why?
|
Animals | 1 | 2020 | 168459 | 0.020 |
Why?
|
Immunotherapy | 1 | 2024 | 4652 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2020 | 2298 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2022 | 22176 | 0.010 |
Why?
|
Concepts
(101)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(40)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_